Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Peek Surgical Screws Market Size & Share 2026-2035
Report ID: GMI14032
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Download Free PDF
Peek Surgical Screws Market
Get a free sample of this reportWhat are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.

PEEK Surgical Screws Market Size
The PEEK surgical screws Market was valued at USD 521 million in 2025, is expected to reach USD 556 million in 2026, and is projected to grow at a 6.6% CAGR (2026-2035) to reach USD 988 million by 2035.
Peek Surgical Screws Market Key Takeaways
Market Leader: Medtronic led with over 20.9% market share in 2025.
Leading Players: Top 5 players in this market include Johnson & Johnson (DePuy Synthes), Stryker, Globus Medical, Zimmer Biomet, Medtronic, which collectively held a market share of 68% in 2025.
The market is advancing as surgeons and care providers place greater value on fixation materials that preserve postoperative imaging clarity while providing a bone-compatible mechanical profile. Demand is reinforced by the growing surgical burden associated with spinal and musculoskeletal conditions, as well as a gradual shift toward outpatient orthopedic and spine care. PEEK's radiolucency remains commercially important where MRI and CT assessment guide fusion monitoring, revision planning, and recovery management.
GMI Analyst View
Based on our discussions with hospital procurement officers, orthopedic distributors, and device-company sales teams across key markets, we estimate that the global PEEK Surgical Screws Market reached approximately USD 490 million in 2024. This pre-base-year performance indicates that material selection is becoming more closely tied to imaging protocols, workflow requirements, and the clinical differentiation of polymer-based fixation systems.
PEEK Surgical Screws Market Trends, Growth Drivers & GMI Forecast Outlook
Demand is shifting toward fixation systems that can support imaging-intensive care pathways and efficient outpatient procedures. Growth is strongest where procedure capacity, reimbursement, and surgeon familiarity support adoption, while premium pricing, regulatory burden, and competition from advanced titanium constructs shape the pace of conversion.
Key Drivers
*Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.*
Low back pain affected approximately 628.8 million people globally in 2021, underscoring the continuing procedural foundation for spinal fixation demand [3]Wang R et al. "Global burden of low back pain and its attributable risk factors from 1990 to 2021." [frontiersin.org]. As referral pathways bring more patients into surgical evaluation, the addressable market for implants that support clear postoperative assessment expands alongside the clinical workload.
The movement of spine procedures into ambulatory settings is also changing the purchasing logic for implants. Outpatient facilities evaluate instruments, packaging, imaging compatibility, and procedural efficiency as a connected workflow rather than as isolated product attributes. That environment favors suppliers able to pair PEEK screw systems with minimally invasive instrumentation, navigation compatibility, and predictable support for surgeons adapting procedures to lower-cost sites of care.
Key Restraints
*Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.*
Premium pricing is a structural hurdle rather than a short-term procurement issue. Surgical-grade PEEK requires specialized material inputs, precision machining, sterilization, and, increasingly, surface engineering. In public systems where reimbursement is standardized and implant budgets are tightly controlled, those costs can limit PEEK adoption to selected complex cases or private-care channels.
Competition within the spine ecosystem adds further complexity. Porous titanium and titanium-coated polymer designs seek to address the osseointegration concerns associated with conventional PEEK while retaining some of its imaging benefits. This does not remove the rationale for PEEK fixation, but it raises the evidentiary and product-design threshold for suppliers seeking to convert surgeons in demanding fusion indications.
Europe's regulatory framework compounds these commercial pressures. Smaller manufacturers may have fewer resources to sustain clinical documentation, notified-body engagement, and post-market evidence generation across specialized screw portfolios. The resulting portfolio rationalization can narrow local product availability and slow the diffusion of differentiated PEEK formats.
GMI Analyst View
We view the principal forecast divide as one between markets where reimbursement and outpatient capacity allow imaging-compatible fixation to move beyond specialist centers, and markets where clinical interest remains ahead of purchasing capacity. The most durable competitive advantage will belong to suppliers that resolve osseointegration concerns without compromising procedural efficiency or radiolucent follow-up.
PEEK Surgical Screws Market Segment Analysis
By Product
Cortical screws accounted for 52.0% of PEEK Surgical Screws Market revenue in 2025 and are projected to generate USD 494 million by 2035.Their leading position reflects broad use in cortical-bone fixation across spinal and trauma procedures. Established surgeon familiarity, applicability across multiple surgical approaches, and integration with navigation-enabled systems make cortical designs a stable base of demand even as hybrid products address more specialized clinical requirements.
Cancellous screws generated USD 161 million in 2025 and are projected to expand at a 6.5% CAGR (2026-2035).This segment is supported by procedures involving spongy bone, including periarticular trauma and reconstructive applications. In patients with compromised bone quality, the appeal of a more bone-compatible material profile can strengthen the clinical case for PEEK, although surgeon confidence in fixation performance remains central to purchasing decisions.
Hybrid screws generated USD 89 million in 2025 and are expected to represent 19.5% of market revenue by 2035.Hybrid formats address a longstanding commercial limitation of conventional PEEK: the need for stronger implant-bone integration in demanding fusion environments. Carbon-fiber reinforcement, porous structures, and bioactive surface technologies can broaden PEEK's relevance where surgeons seek both imaging visibility and enhanced osseointegration.
By Application
Spinal fusion generated USD 198 million in 2025 and is projected to reach USD 369 million by 2035.The segment remains the central procedural anchor for PEEK surgical screws because postoperative imaging is integral to evaluating alignment, fusion progression, and complications. The migration of selected fusion procedures toward outpatient settings further increases the importance of implant systems that work reliably with minimally invasive and navigation-assisted workflows.
Trauma fixation represented 24.0% of market revenue in 2025 and is projected to generate USD 226 million by 2035.Demand is shaped by the need for fixation options that support imaging-guided assessment in long-bone and periarticular injuries. PEEK's clinical relevance is strongest where hardware visibility on postoperative imaging, soft-tissue compatibility, and load transfer are important to the treating surgeon's decision.
Joint replacement is projected to generate USD 173 million by 2035 and represented 18.0% of market revenue in 2025.PEEK screws serve primarily as ancillary fixation components in complex primary and revision arthroplasty rather than as substitutes for the metallic materials used in core joint implants. This creates a stable but more measured opportunity tied to reconstruction complexity, surgeon preference, and the use of imaging-sensitive adjunct fixation.
Dental implants are expected to represent 14.3% of market revenue by 2035 and are projected to grow at an 8.5% CAGR (2026-2035).The application benefits from demand for non-metallic aesthetics and the ability to evaluate periimplant structures without metal-related imaging interference. Adoption is particularly relevant in premium dental settings where patient preference, practitioner specialization, and private-pay economics can support higher-value material selection.
Other applications represented 7.9% of market revenue in 2025 and are projected to generate USD 79 million by 2035.This category includes cranio-maxillofacial fixation, soft-tissue-to-bone anchoring, and emerging reconstructive applications. Although fragmented, these uses extend PEEK demand beyond core spine and trauma procedures and create niches for suppliers with specialized implant designs or surgeon relationships.
By End Use
Hospitals generated USD 297 million in 2025 and are projected to reach USD 533 million by 2035.Hospitals remain the primary setting for complex spinal fusion, acute trauma, and revision procedures that require multidisciplinary clinical capacity. Their scale, institutional purchasing pathways, and concentration of orthopedic expertise provide a durable channel for PEEK systems, even as selected procedures shift to outpatient facilities.
Ambulatory surgical centers are projected to generate USD 328 million by 2035 and are expected to grow at a 7.8% CAGR (2026-2035).ASCs reward implant systems that reduce procedural variability and fit efficiently within standardized workflows. PEEK screws can align with this model when paired with minimally invasive instruments, single-use packaging, and reliable imaging follow-up, allowing suppliers to position the material as a practical component of outpatient case management.
Specialty clinics represented 13.1% of market revenue in 2025 and are projected to generate USD 127 million by 2035.Specialty clinics are especially relevant in private orthopedic and dental care, where patient co-pay structures and practitioner preference can support premium implant selection. These settings also provide a route for newer PEEK formats to build clinical familiarity before broader hospital formulary adoption.
GMI Analyst View
We see the segment opportunity moving beyond a conventional spine-and-trauma narrative. The incremental market is increasingly shaped by hybrid screw architectures, outpatient-compatible systems, and dental applications where material choice is influenced by both clinical handling and patient preference. Suppliers that translate material science into simpler procedural adoption will be best positioned to capture this shift.
PEEK Surgical Screws Market Regional Analysis
North America PEEK Surgical Screws Market Analysis
North America represented 44.9% of PEEK Surgical Screws Market revenue in 2025 and is projected to generate USD 441 million by 2035. The region's leadership reflects broad reimbursement support, a concentrated orthopedic and spine-device ecosystem, and extensive surgeon access to imaging-intensive care pathways. Its outpatient infrastructure provides a particularly favorable environment for suppliers able to align PEEK systems with ASC workflow, navigation, and minimally invasive surgical techniques.
United States
The United States generated USD 208 million in 2025 and is projected to reach USD 390 million by 2035. The country combines deep specialist capacity with a mature device-commercialization environment. Its hospital and ASC networks create multiple routes to adoption, while established surgeon education and device-representative coverage support the introduction of differentiated PEEK fixation systems.
Canada
Canada represented 5.0% of global market revenue in 2025 and is projected to grow at a 7.0% CAGR (2026-2035). Canadian adoption is supported by centralized hospital care delivery and the use of imaging-based postoperative protocols in major orthopedic and spine centers. Procurement remains disciplined, but organized academic networks can facilitate adoption once clinical and formulary requirements are met.
Europe PEEK Surgical Screws Market Analysis
Europe generated USD 127 million in 2025 and is projected to grow at a 5.8% CAGR (2026-2035). The regional opportunity is supported by established orthopedic expertise and aging patient populations, but adoption is moderated by reimbursement variation and compliance costs associated with implantable devices. Suppliers with sufficiently documented clinical portfolios and durable local distribution are better placed to sustain access across the region's fragmented health systems.
Germany
Germany generated USD 32 million in 2025 and is projected to reach USD 56 million by 2035. Germany's specialist orthopedic base and private-pay dental market support demand for premium fixation materials. The market favors suppliers that can meet rigorous evidence expectations and maintain dependable access through hospital and specialist procurement channels.
United Kingdom
The United Kingdom is projected to generate USD 39 million by 2035 and grow at a 5.5% CAGR (2026-2035). Public-sector purchasing discipline can slow the adoption of higher-priced fixation materials, particularly where comparative health-economic evidence is limited. Private orthopedic and dental providers remain an important channel for PEEK systems that address specialized procedural needs.
France
France represented 3.5% of global market revenue in 2025 and is projected to generate USD 31 million by 2035. France benefits from an organized orthopedic care network and substantial musculoskeletal treatment capacity. However, reimbursement-listing and price-review processes can create uncertainty for suppliers introducing specialty screws or differentiated hybrid designs.
Asia Pacific PEEK Surgical Screws Market Analysis
Asia Pacific generated USD 116 million in 2025 and is expected to represent 24.6% of market revenue by 2035. Infrastructure investment, expanding private-care capacity, and rising procedure volumes are increasing the region's importance to PEEK suppliers. Commercial outcomes vary widely by country, with regulatory pathways, reimbursement structures, and the pace of surgeon training determining how quickly demand moves beyond high-end urban hospitals.
China
China generated USD 38 million in 2025 and is projected to reach USD 76 million by 2035. The market is supported by expanding tertiary-care infrastructure and a larger base of orthopedic procedures in major cities. Registration requirements create entry barriers for new suppliers, but those barriers also reinforce the advantage of multinational manufacturers and domestic firms that have already established compliant product pathways.
Japan
Japan is projected to generate USD 46 million by 2035 and grow at a 5.0% CAGR (2026-2035). An aging population provides a structural demand base for spinal and orthopedic interventions. Value growth is moderated by pricing controls and rigorous product-approval expectations, making clinical differentiation and reimbursement alignment essential for suppliers operating in the market.
India
India is projected to grow at a 9.5% CAGR (2026-2035) and generate USD 50 million by 2035. Private hospital expansion, medical tourism, and increasing access to advanced spinal care create a strong growth setting for PEEK fixation. Price sensitivity remains significant in public procurement, meaning that near-term adoption is likely to remain concentrated in urban private networks and high-acuity centers.
South Korea
South Korea represented 2.9% of global market revenue in 2025 and is projected to grow at a 7.0% CAGR (2026-2035). The country's advanced dental and orthopedic specialist markets support early use of premium PEEK formulations, particularly where aesthetics and radiolucency matter. Domestic device development also gives the market relevance as both a demand center and a potential source of regional supply.
Latin America PEEK Surgical Screws Market Analysis
Latin America is projected to generate USD 49 million by 2035 and grow at a 6.2% CAGR (2026-2035). Demand is concentrated in private hospitals and specialty practices that can accommodate premium implant pricing. Public tenders remain heavily cost-driven, limiting broader conversion from titanium despite clinical interest in imaging-compatible fixation for complex cases.
Brazil
Brazil generated USD 15 million in 2025 and is projected to reach USD 27 million by 2035. Brazil's large orthopedic procedure base and concentration of private specialty care in major metropolitan areas support PEEK demand. Regulatory requirements and the cost of market entry can lengthen product-introduction cycles, favoring suppliers with established local partners and service capability.
Mexico
Mexico is projected to generate USD 15 million by 2035 and grow at a 6.5% CAGR (2026-2035). Private orthopedic networks, medical tourism activity, and proximity to U.S.-trained surgeons create selective demand for advanced fixation systems. Adoption is most likely where multinational suppliers can provide dependable distribution and where private facilities can absorb premium implant costs.
Middle East & Africa PEEK Surgical Screws Market Analysis
Middle East & Africa represented 3.3% of global market revenue in 2025 and is projected to generate USD 33 million by 2035. The market is emerging from a comparatively small base, with growth concentrated in better-funded Gulf healthcare systems. Investment in domestic surgical capacity and specialist hospitals is increasing the availability of procedures that can support advanced fixation technologies.
Saudi Arabia
Saudi Arabia represented 0.8% of global market revenue in 2025 and is projected to grow at a 7.2% CAGR (2026-2035). Healthcare investment is expanding local capacity for complex orthopedic, spinal, and dental procedures. As hospitals pursue higher-acuity service delivery, procurement standards increasingly reflect international expectations for implant performance, imaging compatibility, and supplier support.
United Arab Emirates
The United Arab Emirates is projected to generate USD 6 million by 2035 and grow at a 7.2% CAGR (2026-2035). The country's private hospital sector and position as a medical-tourism destination create a receptive setting for premium fixation products. Established global suppliers can benefit where advanced surgical services seek differentiated implants that align with international clinical standards.
GMI Analyst View
We believe regional performance will depend less on broad awareness of PEEK than on the local conditions that convert clinical interest into routine purchasing. North America remains structurally advantaged by reimbursement and outpatient capacity, while Asia Pacific presents the largest expansion runway. Europe will reward suppliers that can turn regulatory compliance into durable access rather than treating it as a transactional requirement.
PEEK Surgical Screws Market Share & Competitive Landscape
The PEEK Surgical Screws Market share structure is concentrated among suppliers with broad implant portfolios, regulatory resources, and durable surgeon relationships. The top five companies collectively accounted for approximately 68.0% of global market revenue in 2025, underscoring the importance of scale in navigating qualification requirements, supporting clinical education, and maintaining distribution across hospital and ASC channels.
Medtronic held a 20.9% market share in 2025. Its competitive position is supported by a broad spine ecosystem that connects fixation products with navigation, imaging, and surgical-workflow capabilities. That integrated approach can strengthen account retention, particularly in high-technology hospitals and outpatient settings where procedural standardization is increasingly important.
Johnson & Johnson (DePuy Synthes) held an 18.0% market share in 2025. The company's position reflects an extensive fixation portfolio and the ability to serve open and minimally invasive procedures across spinal indications. Its use of hybrid material strategies also illustrates how major suppliers are addressing the trade-off between radiolucency and osseointegration.
Stryker held a 13.1% market share in 2025. Its commercial reach in orthopedic and ASC channels supports the placement of PEEK-compatible products within broader minimally invasive and sports-medicine workflows. Continued investment in anchors and fixation systems reinforces its ability to participate across multiple orthopedic subspecialties rather than relying solely on spine demand.
Globus Medical occupies a differentiated innovation position through porous PEEK technologies and integrated spinal-fixation platforms. Its focus on surface architecture addresses the clinical concern that has historically limited broader PEEK adoption in high-demand fusion settings, while preserving the material's imaging advantages.
Zimmer Biomet maintains competitive relevance through its established hospital relationships and broad orthopedic portfolio. Its ability to combine PEEK-compatible systems with adjacent knee, shoulder, spine, and biologics offerings supports cross-selling in accounts seeking integrated reconstructive solutions.
Additional competition comes from Arthrex, B. Braun, CoreLink, icotec, Medacta, MicroPort, Orthofix, Precision Spine, Smith & Nephew, and Victrex. These companies compete through specialization in sports medicine, spine reconstruction, carbon-fiber-reinforced PEEK, regional distribution, implant manufacturing, and material-science support. Competitive intensity is likely to increase as suppliers seek to translate surface modification, porous architecture, and outpatient workflow compatibility into differentiated clinical value.
Recent Industry Developments
March 11, 2025 - Globus Medical: Globus Medical commercially launched the COHERE ALIF Spacer and Modulus ALIF Blades. The launch extended the company's anterior interbody portfolio with a porous PEEK spacer designed to support bone ingrowth while retaining PEEK's imaging and biomechanical characteristics, alongside an anchoring-blade extension intended to reduce surgical steps in ALIF procedures [6]Globus Medical. "Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades." [nasdaq.com].
June 24, 2025 - Curiteva: Curiteva announced FDA 510(k) clearance for its Inspire Trabecular PEEK Standalone ALIF System. The development provides commercial validation for additive-manufactured PEEK architectures in lumbar fusion and reinforces the industry's focus on implant surfaces that seek to improve bone integration without sacrificing radiolucency [7]Ortho Spine News. "Curiteva Secures FDA 510(k) Clearance for Inspire Trabecular PEEK Standalone ALIF System." [orthospinenews.com].
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →